NewsBot
08-31-2009, 05:40 PM
HealthDay - MONDAY, Aug. 31 (HealthDay News) -- Mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment, a new study contends.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090831/hl_hsn/prostatecanceroverdiagnosedstudy)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090831/hl_hsn/prostatecanceroverdiagnosedstudy)
(From Yahoo Diseases)